Tuesday, September 16, 2025

Medipharm Labs Sees CEO Pat McCutcheon Step Down From Role, Remain As Chairman

Medipharm Labs (TSX: LABS) this morning announced drastic changes to its leadership role, with the major change being that CEO Pat McCutcheon will be stepping down from his role as CEO, with no permanent replacement named. The result will be that the company will have both an interim CFO and an interim CEO helming the company.

The leadership changes announced this morning are reportedly to “prepare the company for its next phase of growth,” while also focusing on that of efficiency and cost savings. Taking McCutcheon’s role on an interim basis will be that of Keith Stratchan. McCutcheon meanwhile will be remaining with the company in the role of Chairman of the board.

Also outlined this morning is that Warren Everitt will remain as CEO of the Asia Pacific region for the company, while Olga Utkutug has been named as the interim CFO of the company, effective December 8, 2020. The company has yet to find a permanent replacement since Bobby Kwon resigned from the company, effective at the end of November.

The company is said to immediately begin the process of finding a permanent CEO replacement, while that process is already underway for the role of CFO.

Medipharm Labs last traded at $0.55 on the TSX.


.Information for this briefing was found via Sedar and Medipharm Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

New Found Gold: The Strategic Maritime Resources Purchase

Amex Exploration: Revised Perron PEA Has INSANE Economics

Aris Mining: The Multi Billion Dollar Soto Norte PFS

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

Medipharm Labs: Canaccord Lowers Targets After Earnings

On August 16, Medipharm Labs (TSX: LABS) reported their second quarter financial results. The company...

Friday, August 20, 2021, 07:54:00 AM

Medipharm Labs Signs White Label Arrangement With Shelter Brand House

Medipharm Labs (TSX: LABS) announced a white labeling agreement with that of 1193269 B.C. Ltd....

Thursday, January 9, 2020, 08:54:10 AM

Medipharm Labs Posts Revenues of $13.9 Million, Net Loss of $3.5 Million For Q2 2020

Medipharm Labs (TSX: LABS) reported further disappointing quarterly results this morning, with revenues of $13.9...

Thursday, August 13, 2020, 09:25:18 AM

Medipharm Labs Applies for Nasdaq Listing

Medipharm Labs (TSX: LABS) announced this morning that it has submitted an application for listing...

Tuesday, November 5, 2019, 09:37:00 AM

Medipharm Labs Receives Australian Drug Import License

Medipharm Labs (TSX: LABS) announced this morning that the firm has received an importation license...

Friday, January 31, 2020, 09:04:16 AM